Vanitha Ramakrishnan,David Powers,Dale E. Johnson,Ursula Jeffry,Vinay Bhaskar
申请号：
US13009757
公开号：
US08309084B2
申请日:
2011.01.19
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides chimeric and humanized antibodies that specifically recognize α5β1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.
